Stock Search
Search for you Ticker
Find and analyze stocks with comprehensive financial metrics including P/E ratios, dividend yields, and growth indicators. Filter by sector, valuation metrics, and performance to identify investment opportunities.
Company Overview
DANAHER CORP /DE/
Health CareLife Sciences Tools & ServicesDanaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of...
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
Exchange: NYSE
Company Statistics
Profile
Market Cap$165.48B
EV$187.69B
Shares Out707.6M
Revenue$25.11B
Margins
Gross58.5%
Operating20.4%
Pre-Tax19%
Net15.9%
FCF21.8%
Returns (5Yr Avg)
ROA6.3%
ROE10.8%
ROCE7.6%
ROIC7.7%
Valuation (TTM)
P/E41.3
P/B3.1
EV/Sales7.5
P/FCF30.3
EV/Gross Profit12.8
Financial Health
Cash$4.35B
Net Debt$22.21B
Debt/Equity0.5
Growth (CAGR)
Rev 3Yr-2.7%
Rev 5Yr2%
Rev 10Yr5.5%
Dil EPS 3Yr-19.4%
Dil EPS 5Yr0.6%
Dil EPS 10Yr0.6%
FCF 5Yr-0.6%
Shares 5Yr-0.1%
Dividends
Yield0.6%
Payout26.9%
DPS$1.52
DPS Growth 3Yr6.7%
DPS Growth 5Yr10%
DPS Growth 10Yr-26.2%
Price History
No price history available
Financial Performance
Display:
Data reported in USD
Assets vs Liabilities
Data reported in USD
Free Cash Flow
Data reported in USD